![]() |
|
|
|
|||||||
|
|
|
2007-03-30 News Release
Specialty Polymers biz expands coatings for packaging Specialty Polymers business, SolVin, plans second production unit for PVDC latex, a specialty barrier material used as coating in packaging applications.
SolVin, a joint venture between Solvay and BASF, announces today that
it is planning to build a second production unit of Polyvinylidene chloride
(PVDC) latex in response to growing global demand. PVDC latex is a specialty
barrier material used as coating in packaging applications
where the integrity of the goods is critical – essentially in the
food and pharmaceutical sectors.
“The unique properties of polyvinylidene chloride latex, which
SolVin markets under the Diofan* brand name, make it the preferred choice
of the food and pharma industry to match the highest barrier requirements,”
observed Vincenzo Morici, General Manager of the Specialty Polymers Strategic
Business Unit, Solvay. “SolVin intends to uphold its commercial
and technological leadership as well as its global reputation of excellence
for this class of products. We will be in a position to continue serving
our clients’ expansion, while feeding Solvay’s strategy of
sustainable and profitable growth in the Specialty Polymers business,”
Morici added. SolVin is a joint venture of which Solvay owns 75% and BASF, 25%. It
is a leader on the polyvinyl chloride (PVC) market in Europe and on the
PVDC market worldwide.
Click here to view more news headlines.
|
News / Resources - Packaging Solutions Provider to Build Plant in China - Certification, Training and Courses from The American Management Association - Small Quantity Specailist - Plastics, Metals, Tool Steel and ... - Looking for a Study Program? - All this Months News - Changing Jobs? View a Wide Range of Real Estate Nationwide - Golf Equipment Manufacturer -Buy Direct and Save! Copyright - Unless
otherwise stated all
contents of this web site are © 1998/2007 JOBWERX.COM.
– All Rights Reserved. For permission to reproduce any contents of this
web site, please advise our Syndication department: Log onto HELP
|
|
|